Fmr LLC Xilio Therapeutics, Inc. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,395,853 shares of XLO stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,395,853
Previous 1,907,671
26.83%
Holding current value
$1.12 Million
Previous $2.06 Million
35.63%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XLO
# of Institutions
33Shares Held
12.6MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA3.79MShares$3.03 Million0.74% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3MShares$2.4 Million0.09% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.15 Million20.01% of portfolio
-
Morgan Stanley New York, NY1.11MShares$890,1920.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$722,0240.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $22M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...